HST Global Inc. EBITDA Margin

EBITDA Margin of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA Margin growth rates and interactive chart.


Highlights and Quick Summary

  • EBITDA Margin for the quarter ending June 29, 2020 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA Margin decreased by NaN%
  • Annual EBITDA Margin for 2019 was 0.0% (a NaN% decrease from previous year)
  • Annual EBITDA Margin for 2018 was 0.0% (a NaN% decrease from previous year)
  • Annual EBITDA Margin for 2017 was 0.0% (a NaN% decrease from previous year)
  • Twelve month EBITDA Margin ending June 29, 2020 was 0.0% (a NaN% decrease compared to previous quarter)
  • Twelve month trailing EBITDA Margin decreased by NaN% year-over-year
Trailing EBITDA Margin for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
0.0% 0.0% 0.0% 0.0%
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA Margin of HST Global Inc.

Most recent EBITDA Marginof HSTC including historical data for past 10 years.

Interactive Chart of EBITDA Margin of HST Global Inc.

HST Global Inc. EBITDA Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.0% 0.0%
2019 0.0% 0.0% 0.0% 0.0% 0.0%
2018 0.0% 0.0% 0.0% 0.0% 0.0%
2017 0.0% 0.0% 0.0% 0.0% 0.0%
2016 0.0% 0.0% 0.0% 0.0% 0.0%
2015 0.0% 0.0% 0.0% 0.0% 0.0%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 0.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 0.0% 0.0% 0.0% 0.0%
2010 0.0% 0.0% 0.0% 0.0% 0.0%
2009 0.0% 0.0%

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.